pcmv-vegf165
Gene therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jun 20, 2024 (NCT06473740)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Vascular endothelial growth factor ASupplementation
VEGFA supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06473740 | Phase 4 | Jun 20, 2024 | Amur State Medical Academy |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amur State Medical Academy | Academic/Hospital | 1 | 1 | 1 | 2024 |
1 organizations
Page 1 / 1